Dietary and herbal supplements have an important place in oncology supportive care, but integrative medicine (IM) pharmacists need to be extremely cautious about reviewing evidence and making recommendations to balance the risk for adverse events that could worsen patient outcomes, speakers noted during HOPA25, in Portland, Ore.
The challenges to confident recommendations can be daunting, ranging from a dearth of rigorous scientific studies to poor-quality—or even